News
First patient dosed in LINNET Phase 2 study of lorigerlimab in ovarian and other gynecologic cancers Clinical update on LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback